Valuation : Gland Pharma Limited

Market Cap 473B 5.01B 4.32B 4.07B 3.71B 6.93B 6.98B 48.19B 18.7B 242B 18.81B 18.4B 795B P/E 2027 *
36x
P/E 2028 * 29.6x
Enterprise Value 436B 4.61B 3.98B 3.75B 3.42B 6.38B 6.43B 44.38B 17.22B 223B 17.32B 16.94B 732B EV / Sales 2027 *
5.82x
EV / Sales 2028 * 4.96x
Free-Float
48.23%
Yield 2027 *
0.71%
Yield 2028 * 0.78%
1 day-0.23%
1 week+1.55%
Current month-0.60%
1 month+14.60%
3 months+25.13%
6 months+57.41%
Current year+66.57%
1 week 2,803
Extreme 2803
2,930
1 month 2,494.1
Extreme 2494.1
3,039.8
Current year 1,573.6
Extreme 1573.6
3,039.8
1 year 1,573.6
Extreme 1573.6
3,039.8
3 years 1,277.8
Extreme 1277.8
3,039.8
5 years 861
Extreme 861
4,179.65
10 years 861
Extreme 861
4,350
Manager TitleAgeSince
Director of Finance/CFO - 2019-09-29
Chief Operating Officer - 2026-04-05
Chief Tech/Sci/R&D Officer - 2026-02-17
Director TitleAgeSince
Chairman 57 2024-06-09
Director/Board Member 71 2018-02-06
Director/Board Member 69 2021-05-16
Date Insider Type Main position Quantity % Market Cap. Importance
2/26/25 Buy 2,800 0.0017%
6/28/24 Sell 1,950 0.0012%
6/28/24 Sell 1,400 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.23%+1.55%+53.30%+62.23% 5B
+0.01%-2.47%+57.79%+107.83% 1,034B
+1.48%+1.93%+54.56%+71.28% 654B
+0.67%-0.45%+23.50%+79.14% 459B
+0.49%-6.58%+34.20%+34.59% 343B
+0.27%+2.32%+29.33%+46.97% 307B
+0.12%-4.01%+1.06%+11.93% 251B
+1.08%+0.57%+54.34%+74.34% 237B
+2.64%-2.00%-17.38%-53.64% 202B
-0.21%+1.03%+32.74%+99.06% 186B
Average +0.65%-2.41%+32.35%+53.37% 367.66B
Weighted average by Cap. +0.65%-3.31%+38.87%+67.78%

Financials

2027 *2028 *
Net sales 74.93B 793M 684M 645M 587M 1.1B 1.11B 7.63B 2.96B 38.31B 2.98B 2.91B 126B 85.84B 909M 784M 738M 673M 1.26B 1.27B 8.74B 3.39B 43.89B 3.41B 3.34B 144B
Net income 13.12B 139M 120M 113M 103M 192M 194M 1.34B 519M 6.71B 522M 510M 22.03B 15.95B 169M 146M 137M 125M 234M 235M 1.62B 630M 8.15B 634M 620M 26.78B
Net Debt -37.45B -396M -342M -322M -294M -549M -553M -3.81B -1.48B -19.15B -1.49B -1.46B -62.9B -47.28B -501M -432M -407M -371M -693M -698M -4.82B -1.87B -24.17B -1.88B -1.84B -79.41B
Logo Gland Pharma Limited
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.
Employees
4,332
Date Price Change Volume
26-09-02 2,868.40 -0.23% 556,481
26-09-01 ₹2,875.00 -0.37% 257,559
26-08-31 ₹2,885.80 -0.08% 370,779
26-08-28 ₹2,888.00 +0.50% 165,191
26-08-27 ₹2,873.50 -1.02% 129,706
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,868.40INR
Average target price
2,856.07INR
Spread / Average Target
-0.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GLAND Stock